New Alzheimer’s medication approved by FDA
The US Food and Drug Administration (FDA) has approved a new drug for the treatment of Alzheimer’s disease — the first of its kind for twenty years. What does this mean for those affected by Alzheimer’s disease in India? Aducanumab, from the company Biogen, is a monoclonal antibody that aims to slow the gradual progression …